XML 36 R25.htm IDEA: XBRL DOCUMENT v3.25.1
Organization and Basis of Presentation (Details Narrative) - USD ($)
3 Months Ended
Jun. 02, 2023
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Aug. 19, 2024
Dec. 31, 2023
Apr. 09, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Minimum net stockholders equity maintaining in nasdaq $ 2,500,000            
Stock holders' equity   $ (1,159,130) $ (3,126,367) $ (827,219)   $ (3,994,762)  
Net loss   709,555 971,322        
Net cash used in operations   568,483 789,225        
Cash   1,384,697   1,038,952     $ 40,000
Clinical Trial Agreements and Clinical Trial Monitoring Agreements [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Contractual obligation   514,000          
Minimum [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Stock holders' equity         $ 2,500,000    
Common Stock [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Reverse stock split 1-for-10            
Stock holders' equity   (268) (225) $ (225)   $ (225)  
Net loss          
Common Stock [Member] | Minimum [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Bid price $ 1.00